Joint pain — separating the common from the treatable
Two test results cause more unnecessary worry here than any others: a raised uric acid and a low vitamin D. Both are extremely common in people with no joint disease at all, which is exactly why neither explains one person's pain.
গাঁটে ও শরীরে ব্যথা — কোনটা ক্ষয়, কোনটা প্রদাহ, আর ইউরিক অ্যাসিড ও ভিটামিন ডি-র রিপোর্ট নিয়ে কতটা চিন্তা করা দরকার।
In Indian community surveys, the commonest cause of joint and body pain is soft-tissue rheumatism, followed by osteoarthritis; inflammatory arthritis accounts for under 1% of adults. In one rural survey of 2,259 adults, soft-tissue rheumatism affected 28.0%, osteoarthritis 11.4%, rheumatoid arthritis 0.4% and gout 0%. Two commonly ordered tests mislead: hyperuricaemia was found in 32.7% of rural Indian adults while clinical gout is essentially absent from community surveys, and vitamin D deficiency affects 30–91% of Indians depending on the cut-off, including 51% of rural West Bengal postmenopausal women. A test abnormal in half the population cannot explain one person's symptom. Skeletal fluorosis and arsenic exposure affect other West Bengal districts, not Cooch Behar. Dr Soumya Ghosh, MD (General Medicine), assesses joint pain at Uttarbanga Clinic, Sunity Road, Cooch Behar.
Do not wait for an appointment if any of these apply
- A single hot, red, exquisitely painful, swollen joint — especially with fever
- Joint pain with a fever that has lasted more than a few days
- Back pain with weakness in the legs, numbness in the saddle area, or loss of bladder or bowel control
- Joint pain with a new rash, mouth ulcers or eye redness
- Sudden severe back pain after a minor fall in someone over 60
- Joint pain with unintended weight loss or night sweats
Call 108 or go directly to the emergency department at MJN Medical College & Hospital, Cooch Behar. Do not drive yourself.
A single acutely hot, swollen joint is septic arthritis until proven otherwise. It destroys a joint within days and needs the fluid aspirated in hospital, not an anti-inflammatory tablet.
Key facts
- In a rural Indian community survey, soft-tissue rheumatism affected 28.0% of adults, osteoarthritis 11.4%, rheumatoid arthritis 0.4% and gout 0%.
- 32.7% of rural Indian adults in one survey had a raised uric acid, against a community gout prevalence of 0–0.13%. A high uric acid is not gout.
- 51% of rural postmenopausal women in West Bengal are vitamin D deficient — a finding too common to explain any individual's pain.
- 4.08% of healthy North Indians carry HLA-B27, against an axial spondyloarthritis prevalence of about 0.23%. A positive test in mechanical back pain usually means a healthy carrier.
- Ankylosing spondylitis in India is diagnosed a mean of 6.9 years after symptoms begin; 16.6% had been misdiagnosed as spinal tuberculosis.
What joint pain usually turns out to be
The word "arthritis" gets applied to almost any pain from the neck to the ankles, and it carries an implication — a progressive inflammatory disease — that is wrong most of the time. The community data are clear about the proportions.
In a rural community survey of 2,259 adults with 89% participation, the commonest rheumatic disorder by a wide margin was soft-tissue rheumatism at 28.0% (26.1–29.8) — tendon, bursa and muscle pain rather than joint disease. All arthritis together accounted for 12.2%, osteoarthritis 11.4%, knee osteoarthritis 8.9%, rheumatoid arthritis 0.4%, spondyloarthropathy 0.2%, and gout 0% — not one case.[1] The large multisite COPCORD study of 56,541 Indians found the same ordering: musculoskeletal pain at a point prevalence of 16.14% (rural 20%, urban 10.3%), osteoarthritis 4.39%, rheumatoid arthritis 0.34%, spondyloarthritis 0.23%, gout 0.05%.[2]
Knee osteoarthritis specifically is common: 28.7% in a five-site Indian community study using formal radiographic grading, and significantly more in women (31.6%).[3]
There is a West Bengal figure worth putting alongside these. Among rural elderly people in Singur, Hooghly, 56.8% had chronic musculoskeletal pain, most often in the knee (49.6%) and low back (33.1%).[4] Yet in the national LASI survey of adults aged 45 and over, West Bengal recorded the lowest self-reported musculoskeletal disorder of any Indian state — 33.1%, against a national 53.5%.[5] Read together, those two say something specific: symptoms here are at least as common as anywhere in India, but the diagnosis is not being made. That is under-recognition, not low disease.
The two reports that worry people unnecessarily
Uric acid
A raised uric acid on a report is one of the commonest reasons someone arrives convinced they have gout. The numbers do not support it. In a survey of 300 rural adults over 30 in Karnataka, 32.7% had hyperuricaemia[6] — roughly one adult in three. Community gout prevalence in Indian surveys is 0% to 0.13%.[1][2]
So a raised uric acid is around 250 times more common than the disease it is supposed to indicate. Gout is a clinical diagnosis — a sudden, severe, red, hot joint, classically the base of the big toe, resolving over days — and the uric acid level may even be normal during an attack. Treating an asymptomatic raised uric acid to explain diffuse body ache treats a number rather than a person.
Vitamin D
The same logic applies more strongly. Vitamin D deficiency in Indian adult studies ranges from 30% to 91.2% depending on the cut-off used.[7] In rural West Bengal specifically, 51% of postmenopausal women in Singur were deficient below 20 ng/ml, with a further 19% insufficient.[8]
A finding present in half or more of the healthy population has almost no discriminating power as an explanation for one individual's symptom. That does not mean vitamin D should never be replaced — deficiency is worth correcting, particularly in older people and for bone health. It means that finding it does not close the case, and if the pain persists after replacement, the original question is still open. In practice, a great many people in this district have been given vitamin D sachets in place of a diagnosis.
Inflammatory or mechanical? The question that actually matters
This distinction does more work than any test, and it is made from the history.
- Inflammatory pattern
- Stiffness in the morning lasting more than 30 to 60 minutes. Pain and stiffness better with movement and worse with rest. Swelling of the small joints of the hands and feet, symmetrically. Waking in the second half of the night. Fatigue. This pattern needs blood tests and, usually, referral.
- Mechanical or degenerative pattern
- Brief stiffness after rest, easing within minutes. Pain worse with use and at the end of the day, better with rest. Larger weight-bearing joints — knees, hips, low back. Crepitus. This is osteoarthritis, and its treatment is largely weight, muscle strength and activity rather than tablets.
- Soft-tissue pattern
- Pain localised to one point rather than a joint line — the outer shoulder, the outer hip, the heel, the elbow. Tender to press on that spot. Full but painful movement. This is the commonest category of all and it usually settles with specific treatment rather than long-term painkillers.
Back pain that is inflammatory
Axial spondyloarthritis is the diagnosis most often missed, and the delay is measurable: Indian patients with ankylosing spondylitis were diagnosed a mean of 6.9 ± 5.2 years after symptoms began. They had been labelled non-specific back pain (35.1%), degenerative disc disease (25.9%), rheumatoid arthritis (20.4%) and — relevant in a TB-endemic district — spinal tuberculosis (16.6%). The wrong initial diagnosis was made by orthopaedic surgeons in 75.9% of cases and general physicians in 50%.[9]
The clue is that the back pain is inflammatory: it began before 45, came on gradually, is worse with rest and in the second half of the night, improves with exercise, and responds well to anti-inflammatories. Young men with years of "just back pain" that fits that description should be reassessed.
One caution on testing: 4.08% of healthy North Indians carry HLA-B27,[10] against an axial spondyloarthritis prevalence of about 0.23%. A positive HLA-B27 in someone with ordinary mechanical back pain is far more often a healthy carrier than a diagnosis, and the test is useful only when the clinical picture already fits.
Joint pain after a fever: chikungunya
This is a genuine and under-recognised cause of chronic joint pain in West Bengal. In the 2016 outbreak, 24.64% of 641 symptomatic patients in West Bengal tested positive for chikungunya,[11] and in Kolkata between 2020 and 2022, 15.1% of dengue-negative febrile patients were chikungunya-positive by ELISA, with the ECSA genotype circulating and cases peaking in September.[12]
How long the joint pain lasts depends on which study you read, and the difference is instructive. A global meta-analysis of 6,532 patients, mostly hospital-based, found 43% had not recovered at three months and 21% at twelve months.[13] An Indian community cohort following an entire village after the 2006 epidemic found a much lower burden: 4.1% of the whole village population still had musculoskeletal pain at twelve months, and true chronic inflammatory arthritis in only 0.3%, with 65% of acute illness resolving within four weeks.[14] The hospital figure counts those unwell enough to attend; the community figure counts everyone. Both are true of different populations.
Dengue behaves differently and it is worth separating them. In a prospective cohort, persistent symptoms at three months affected 25% after dengue against 69% after chikungunya, and at twelve months 5% against 17% — and dengue produced musculoskeletal symptoms without arthritis, where chikungunya produced genuine joint inflammation.[15] Persistent joint pain after dengue is uncommon and usually settles; after chikungunya it is common and sometimes needs treating as inflammatory arthritis.
Two things this district does not have
Both are worth stating explicitly, because both circulate as explanations for body pain in West Bengal and neither applies here.
Skeletal fluorosis. High-fluoride groundwater in West Bengal is a problem of the western plateau and one North Bengal district: Bankura, Purulia, Birbhum, Dakshin Dinajpur (701 habitations, about 252,000 people, 17% of habitations), Uttar Dinajpur, Malda and one block of South 24 Parganas — 43 blocks across 7 districts, about 615,000 people above 1.5 mg/L.[16] Cooch Behar is not among them; North Bengal samples from Jalpaiguri, Darjeeling and Siliguri measured 0.25–0.46 mg/L, within safe limits.[17] Fluorosis is worth considering only where there is a specific history of living in an affected district — Dakshin Dinajpur being the relevant one for people who have moved.
Arsenic. The arsenic belt of West Bengal lies east of the Ganga — Nadia, Murshidabad, North 24 Parganas, Malda, and parts of Bardhaman, Hooghly and South 24 Parganas.[16] Cooch Behar is not on that list. More importantly, chronic arsenic exposure causes skin changes, cancers, vascular and respiratory disease and peripheral neuropathy — it is not an established cause of arthritis. Burning feet and tingling from arsenic neuropathy can be described as joint pain by a patient, but that is a different problem with a different investigation.
The painkiller question
Long-term NSAIDs are the default treatment for joint pain here and they carry real cost. An Indian prescribing audit found fixed-dose NSAID combinations in about 35% of orthopaedic outpatient prescriptions, with only 40% co-prescribed a gastroprotective agent and 32% receiving COX-1 inhibitors with none at all.[18] Among rural elderly in Singur, chronic pain was strongly associated with over-the-counter analgesic self-medication.[4] This is the direct link to the acidity guide: 22% of patients with upper GI bleeding in an eastern India series had been taking NSAIDs.
Steroid injections into a knee are useful in the right situation but their benefit may last under four weeks, and repeated injections carry potential harm including cartilage loss; across international guidelines the consensus is "recommended with caution".[19] An injection given repeatedly by someone who has not examined or imaged the knee is not treatment.
What is done at the consultation
The pattern first — inflammatory, mechanical or soft-tissue — from the history and the examination, because that determines everything else. Then blood count, ESR or CRP, and, where the pattern is inflammatory, rheumatoid factor and anti-CCP. Uric acid and vitamin D are checked when there is a reason, and interpreted against how common abnormal results are. X-rays where they will change something. Referral to rheumatology or orthopaedics where the answer lies there, said plainly rather than deferred.
সংক্ষেপে (বাংলায়)
গাঁটে ব্যথা মানেই বাত নয়। ভারতের গ্রামীণ সমীক্ষায় দেখা গেছে সবচেয়ে সাধারণ কারণ আসলে পেশি ও লিগামেন্টের ব্যথা (২৮%), তারপর ক্ষয়জনিত বাত বা অস্টিওআর্থ্রাইটিস (১১.৪%), আর রিউমাটয়েড আর্থ্রাইটিস মাত্র ০.৪%। দুটি রিপোর্ট নিয়ে বাড়তি চিন্তা হয়: ইউরিক অ্যাসিড ও ভিটামিন ডি। গ্রামীণ ভারতে ৩২.৭% মানুষের ইউরিক অ্যাসিড বেশি, অথচ প্রকৃত গাউট ০–০.১৩%; আর পশ্চিমবঙ্গের গ্রামে ৫১% মহিলার ভিটামিন ডি কম। এত বেশি লোকের যেটা কম, সেটা দিয়ে একজনের ব্যথা ব্যাখ্যা করা যায় না। কোচবিহারে ফ্লুরোসিস বা আর্সেনিকের সমস্যা নেই — এগুলি পশ্চিমবঙ্গের অন্য জেলার সমস্যা।
Frequently asked questions
My uric acid is high. Is that why my joints hurt?
Almost certainly not. About one rural Indian adult in three has a raised uric acid, while gout appears in 0% to 0.13% of people in community surveys — the abnormal number is roughly 250 times commoner than the disease. Gout is diagnosed clinically: a sudden, severe, hot, red joint, classically the big toe, settling over days. Diffuse aching in several joints is not gout, and lowering an asymptomatic uric acid will not fix it.
My vitamin D is low. Will taking it cure my body ache?
It may help, and deficiency is worth correcting for bone health. But between 30% and 91% of Indian adults are deficient depending on the cut-off, and in rural West Bengal 51% of postmenopausal women are — a finding that common cannot explain one person's pain. If your ache persists after replacement, the original question has not been answered, and that is when it needs looking at properly rather than repeating the sachets.
I had chikungunya and my joints still hurt months later. Is that normal?
It is well recognised. Studies differ on how common it is because they count different populations — a hospital-based meta-analysis found 21% still affected at twelve months, while an Indian whole-village community study found musculoskeletal pain in 4.1% of the population at a year and true inflammatory arthritis in 0.3%. Either way it is real, and persistent post-chikungunya joint inflammation is treatable rather than something to endure.
I have had back pain since my twenties and nobody has found a cause.
That is worth reassessing, particularly if the pain is worse with rest and better with movement, wakes you in the second half of the night, and improves markedly with anti-inflammatories. Inflammatory back pain in India is diagnosed on average 6.9 years after symptoms start, and it is commonly mislabelled as non-specific back pain, disc disease or even spinal tuberculosis. A positive HLA-B27 alone does not make the diagnosis — 4% of healthy people carry it — but the clinical pattern plus the test does.
Is my joint pain from the water here — fluoride or arsenic?
No. Cooch Behar is not in either affected zone. High-fluoride groundwater in West Bengal is a problem of Bankura, Purulia, Birbhum and Dakshin Dinajpur; North Bengal samples measure well within safe limits. The arsenic belt lies east of the Ganga in Nadia, Murshidabad and North 24 Parganas. And arsenic, in any case, does not cause arthritis — it causes skin changes, certain cancers and nerve damage.
Assessment of joint pain with Dr Soumya Ghosh
Uttarbanga Clinic, Sunity Road, near Police Line Chowpathi, Ward 20, Cooch Behar 736101. Monday to Saturday, 10:00–20:00. Walk-in or book ahead.
Related guides
References and guidelines
- Joshi VR, et al. Clinical pattern and prevalence of rheumatic diseases among adults: a community-based cross-sectional study in rural Gadchiroli, India. J Glob Health Rep 2021;5:e2021040. doi:10.29392/001c.22240
- Chopra A. Disease burden of rheumatic diseases in India: COPCORD perspective. Indian J Rheumatol 2015;10(2):70–77; and Chopra A, Mathew AJ, Handa R, et al. A high prevalence of musculoskeletal pain and arthritis in India: a multisite WHO-ILAR COPCORD project. Int J Rheum Dis 2025;28:e70163. copcord.org
- Pal CP, Singh P, Chaturvedi S, Pruthi KK, Vij A. Epidemiology of knee osteoarthritis in India and related factors. Indian J Orthop 2016;50(5):518–522. doi:10.4103/0019-5413.189608
- Sengupta P, Paul B, Banerjee R, Das DK, Halder A. Chronic musculoskeletal pain among elderly individuals in a rural area of West Bengal: a mixed-method study. Malays Fam Physician 2023;18:25. doi:10.51866/oa.232
- Kiran T, et al. Prevalence and association of musculoskeletal disorders with various risk factors among older Indian adults. PLOS ONE 2024;19(10):e0299415. doi:10.1371/journal.pone.0299415
- Muthusamy S, Kulkarni RR, Khot PB. Prevalence of hyperuricaemia among rural adults. Natl J Community Med 2024;15(1). doi:10.55489/njcm.150120243381
- Kamboj P, Dwivedi S, Toteja GS. Prevalence of hypovitaminosis D in India and way forward. Indian J Med Res 2018;148(5):548–556. doi:10.4103/ijmr.IJMR_1807_18
- Srimani S, Saha I, Chaudhuri D. Prevalence and association of metabolic syndrome and vitamin D deficiency among postmenopausal women in a rural block of West Bengal, India. PLOS ONE 2017;12(11):e0188331. doi:10.1371/journal.pone.0188331
- Aggarwal R, Malaviya AN. Diagnosis delay in patients with ankylosing spondylitis: factors and outcomes — an Indian perspective. Clin Rheumatol 2009;28(3):327–331. doi:10.1007/s10067-008-1049-z
- Mishra VC, Chandra D, Raina A, Pandey A, Raina V. Prevalence of HLA-B*27 in the North Indian population. Indian J Med Sci 2025;77(3):148–151. doi:10.25259/IJMS_131_2024
- Sengupta S, Mukherjee S, Haldar SK, Bhattacharya N, Tripathi A. Re-emergence of chikungunya virus infection in eastern India. Braz J Microbiol 2020;51:177–182. doi:10.1007/s42770-019-00212-0
- Chatterjee RP, Chatterjee A, Ansari S, et al. Molecular identification and phylogenetic analysis of chikungunya virus among dengue-negative patients in Kolkata, India. PLOS ONE 2024;19(4):e0301644. doi:10.1371/journal.pone.0301644
- Paixão ES, Rodrigues LC, Costa MCN, et al. Chikungunya chronic disease: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg 2018;112(7):301–316. doi:10.1093/trstmh/try063
- Chopra A, Anuradha V, Ghorpade R, Saluja M. Acute chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study. Epidemiol Infect 2012;140(5):842–850. doi:10.1017/S0950268811001300
- Hamer DH, et al. Frequency and persistence of post-acute symptoms after chikungunya, dengue, Zika and malaria in travellers. J Travel Med 2026;33(5):taag037. doi:10.1093/jtm/taag037
- British Geological Survey for the Asian Development Bank. Arsenic and Fluoride in Drinking Water in West Bengal: Characteristics, Implications and Mitigation, 2017. adb.org
- Datta AK, Chakrabortty A, De Dalal SS, Lahiri SC. Fluoride contamination of groundwater in West Bengal, India. Fluoride 2014;47(3):241–248. fluorideresearch.org
- Kandasamy G, et al. A study of prescribing patterns for non-steroidal anti-inflammatory drugs in a tertiary care teaching hospital. Indian J Pharm Sci 2021;83(2). ijpsonline.com
- Pavone V, Vescio A, Turchetta M, et al. Injection-based management of osteoarthritis of the knee: a systematic review of guidelines. Front Pharmacol 2021;12:661805. doi:10.3389/fphar.2021.661805
This page is general health information written and reviewed by a registered medical practitioner. It is not medical advice, does not create a doctor–patient relationship, and is not a substitute for consultation with a doctor who has examined you. Diagnosis and treatment are individualised after clinical assessment. Medicines mentioned here are prescription-only and must be taken under medical supervision. See the editorial and medical review policy. Last reviewed .